StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | BEAM Beam Therapeutics | $26.81 | +0.00% | — | — | — | — | — | 39 |
| 1 | LLY Eli Lilly | $1021.41 | +3.37% | — | — | — | — | — | 76 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $45.53 |
| +4.38% |
| — |
| — |
| — |
| — |
| — |
| 74 |
| 3 | AMGN Amgen | $330.75 | +1.96% | — | — | — | — | — | 69 |
| 4 | MRNA Moderna | $45.72 | -4.97% | — | — | — | — | — | 62 |
| 5 | GILD Gilead Sciences | $130.50 | +0.64% | — | — | — | — | — | 62 |
| 6 | NVO Novo Nordisk | $44.28 | +0.00% | — | — | — | — | — | 58 |
| 7 | REGN Regeneron | $630.30 | +0.10% | — | — | — | — | — | 56 |
| 8 | VRTX Vertex Pharma | $434.31 | -0.52% | — | — | — | — | — | 48 |
| 9 | BNTX BioNTech | $87.79 | -1.19% | — | — | — | — | — | 38 |